14C-labeled gilteritinib
Showing 1 - 25 of 2,320
Healthy Subjects, Pharmacokinetics of 14C-labeled of LXI-15028 Trial in Suzhou ([14C]LXI-15028)
Completed
- Healthy Subjects
- Pharmacokinetics of 14C-labeled of LXI-15028
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
May 22, 2023
Healthy Male Subjects Trial in Tokyo ([14C] TS-142)
Completed
- Healthy Male Subjects
- [14C] TS-142
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022
Healthy Participants Trial in Groningen ([14C]-etrumadenant)
Completed
- Healthy Participants
-
Groningen, NZ, NetherlandsPRA Health Sciences (PRA) - Early Development Services (EDS)
Dec 6, 2022
Healthy Volunteers Trial in Madison (14C-labeled ASP0367)
Completed
- Healthy Volunteers
- 14C-labeled ASP0367
-
Madison, WisconsinLabcorp CRU
May 24, 2022
Healthy Trial in Madison (Radio-labeled rodatristat ethyl 600 mg)
Completed
- Healthy
- Radio-labeled rodatristat ethyl 600 mg
-
Madison, WisconsinCovance Clinical Research Unit
Jul 12, 2022
Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem
Recruiting
- Acute Myeloid Leukemia (AML)
- Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
- gilteritinib
- +3 more
-
Cincinnati, Ohio
- +18 more
Jan 20, 2023
Healthy Volunteers, Type 2 Diabetes Trial in Groningen (NNC0113-6861, NNC0113-6860, NNC0113-6891)
Completed
- Healthy Volunteers
- Type 2 Diabetes
- NNC0113-6861
- +2 more
-
Groningen, NetherlandsNovo Nordisk Investigational Site
Apr 28, 2022
Advanced Solid Tumors, Pharmacokinetics of 14C-labeled Gilteritinib Trial in Cleveland (gilteritinib, 14C-labeled gilteritinib)
Completed
- Advanced Solid Tumors
- Pharmacokinetics of 14C-labeled Gilteritinib
- gilteritinib
- 14C-labeled gilteritinib
-
Cleveland, OhioSite US10001
Mar 13, 2019
Malaria Trial in Allschwil (14C-labeled Pyronaridine)
Completed
- Malaria
- 14C-labeled Pyronaridine
-
Allschwil, Basel, SwitzerlandCovance Clinical Research Unit AG
Nov 18, 2021
Solid Tumor Trial in Pittsburgh (14C-labeled poziotinib)
Terminated
- Solid Tumor
- 14C-labeled poziotinib
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jun 14, 2021
Tuberculosis, Tuberculosis, Pulmonary, Bacterial Infections Respiratory Trial in Groningen (500mg BTZ-043 containing 3.7 MBq of
Completed
- Tuberculosis
- +4 more
- 500mg BTZ-043 containing 3.7 MBq of [14C]BTZ-043
-
Groningen, NetherlandsPRA Health Sciences (PRA) - Early Development Services (EDS)
Oct 19, 2021
Pulmonary Arterial Hypertension Trial in Groningen (400 mg BIA 5-1058)
Completed
- Pulmonary Arterial Hypertension
- 400 mg BIA 5-1058
-
Groningen, NetherlandsPRA Health Sciences (PRA) - Early Development Services (EDS)
Jul 28, 2021
Healthy Volunteers Trial in Nottingham ([12C] RO7049389, [13C] RO7049389, [14C] RO7049389)
Completed
- Healthy Volunteers
- [12C] RO7049389
- +2 more
-
Nottingham, United KingdomQuotient Sciences
Jul 21, 2021
COPD (COPD) Trial in Lincoln (TD-4208)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
-
Lincoln, NebraskaCelerion
Feb 22, 2022
Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)
Active, not recruiting
- Acute Myeloid Leukemia
- Gilteritinib
- +3 more
-
Scottsdale, Arizona
- +43 more
Nov 17, 2022
Healthy Trial in Zuidlaren (IPI-145)
Completed
- Healthy
-
Zuidlaren, NetherlandsPharmaceuticals Research Association (PRA)
Mar 15, 2021
Healthy Trial in San Antonio (14C PER977)
Completed
- Healthy
- 14C PER977
-
San Antonio, TexasWorldwide Clinical Trials Early Phase Services
May 19, 2020
Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation Trial in Worldwide
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
-
Los Angeles, California
- +110 more
Jan 26, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Worldwide (Gilteritinib, Midostaurin)
Suspended
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome With Excess Blasts-2
-
Adelaide, Australia
- +193 more
Jan 5, 2023
Healthy Volunteers Trial in Groningen ([14C]-CRN00808, CRN00808)
Completed
- Healthy Volunteers
-
Groningen, NetherlandsPRA Health Sciences
Jan 27, 2020
Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle-Cell Lymphoma Trial in Bebington, Liverpool (Tazemetostat
Completed
- Diffuse Large B Cell Lymphoma
- +5 more
- Tazemetostat and [14C] Tazemetostat
-
Bebington, Wirral, United Kingdom
- +1 more
Jan 8, 2020
Mass Balance Study in Healthy Subjects Trial in Suzhou ([14C]JAB-21822)
Not yet recruiting
- Mass Balance Study in Healthy Subjects
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jun 25, 2023